PALVELLA THERAPEUTICS INC NE

Ticker: PVLA CUSIP: 697947109 Class: Common Stock

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 722,400 Value ($000) $75,614 Avg Close $85.31 Range $60.49 - $114.69

Q3 2025

Shares 722,400 Value ($000) $45,287 Avg Close $44.59 Range $21.55 - $65.57

Q2 2025

Shares 722,400 Value ($000) $16,283 Avg Close $23.47 Range $18.23 - $28.71

Q1 2025

Shares 690,012 Value ($000) $19,313 Avg Close $19.27 Range $11.28 - $29.27

Q4 2024

Shares 653,892 Value ($000) $7,847 Avg Close $15.71 Range $11.17 - $17.70

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	722,400	$75,614	$85.31	$60.49 - $114.69
Q3 2025	722,400	$45,287	$44.59	$21.55 - $65.57
Q2 2025	722,400	$16,283	$23.47	$18.23 - $28.71
Q1 2025	690,012	$19,313	$19.27	$11.28 - $29.27
Q4 2024	653,892	$7,847	$15.71	$11.17 - $17.70